{"title":"Astrocytic ADCY8-VEGFA signaling is required for dendritic morphogenesis, neuronal activity and contextual fear memory","authors":"Miao-Miao Wang, Meng Tian, Ran Wei, Xin-Yao Zhang, Zhi-Yue Chen, Hai-Wei Zha, Zi-Jie Liu, Xiao-Xuan Li, Zhi-Yuan Hu, Si-Han Zhang, Chun-He Zhang, Hui Wu, Zhen-Jiang Liu, Bin Yu, Xiao-Juan Zhu, Dong Sun","doi":"10.1038/s41418-026-01899-z","DOIUrl":"https://doi.org/10.1038/s41418-026-01899-z","url":null,"abstract":"Contextual fear memory is a hippocampus-dependent and precisely regulated process. Its dysregulation is associated with numerous neuropsychiatric disorders, including post-traumatic stress disorder. However, the mechanisms underlying the expression of this memory remain incompletely elucidated. Here, we provide evidence that astrocytic, rather than neuronal, adenylate cyclase 8 (ADCY8) regulates contextual fear memory. Single-nucleus RNA sequencing analysis suggests that Adcy8-positive astrocytes are more likely to respond to fear conditioning and to modulate synaptic functions. Conditional knockout (CKO) of Adcy8 in astrocytes impairs dendritic morphogenesis, suppresses ventral CA1 (vCA1) neuron activation, and disrupts contextual fear memory retrieval. Further studies identify vascular endothelial growth factor A (VEGFA) as a key downstream effector of ADCY8 in astrocytes, and its expression is substantially decreased in the ventral hippocampus of astrocytic Adcy8 CKO mice by inhibiting the mitogen-activated protein kinase (MAPK) signaling. Knockdown of Vegfa in vCA1 astrocytes recapitulates the phenotypes observed in astrocytic Adcy8 CKO mice. In contrast, overexpression of Vegfa in vCA1 astrocytes not only rescues contextual fear memory deficits but also reverses the neuronal abnormalities in astrocytic Adcy8 CKO mice. Together, these results reveal a novel role of the astrocytic ADCY8-MAPK-VEGFA axis in governing astrocyte-neuron crosstalk, which is required for dendritic morphogenesis, neuronal activity, and contextual fear memory retrieval.","PeriodicalId":9731,"journal":{"name":"Cell Death and Differentiation","volume":"1 1","pages":""},"PeriodicalIF":12.4,"publicationDate":"2026-11-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149397289","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Yan Xu, Houshun Fang, Yao Chen, Yanyan Lin, Huiying Sun, Renate Kirschner-Schwabe, Barz Malwine Jeanette, Bin-Bing S. Zhou, Hui Li
{"title":"Purine metabolite accumulation suppresses mTORC1 through the TUFM-RHEB axis","authors":"Yan Xu, Houshun Fang, Yao Chen, Yanyan Lin, Huiying Sun, Renate Kirschner-Schwabe, Barz Malwine Jeanette, Bin-Bing S. Zhou, Hui Li","doi":"10.1038/s41418-026-01905-4","DOIUrl":"https://doi.org/10.1038/s41418-026-01905-4","url":null,"abstract":"Purine homeostasis is essential for numerous cellular processes. Although purine metabolite accumulation occurs in various pathological and therapeutic contexts, the cellular consequences and underlying mechanisms remain poorly understood. In this study, we utilized gain-of-function mutations in phosphoribosylpyrophosphate synthetase 1 (PRPS1) as a model of intracellular purine accumulation and discovered that elevated purines—particularly deoxyguanosine (dG)—suppressed the mTORC1 signaling pathway. We identified elongation factor Tu (TUFM) as a novel regulator of RHEB by stabilizing its GTP/GDP binding. Accumulation of dG enhanced phosphorylation of RHEB at Ser130, triggering dissociation of both TUFM and guanine nucleotides from RHEB, thereby reducing RHEB activity and downstream mTORC1 signaling. Notably, similar suppression of mTORC1 and loss of TUFM binding were observed upon inhibition of xanthine dehydrogenase/oxidase, another condition associated with purine buildup. Together, these findings reveal a previously unrecognized regulatory crosstalk between purine metabolism and the mTORC1 pathway, mediated through the TUFM-RHEB axis.","PeriodicalId":9731,"journal":{"name":"Cell Death and Differentiation","volume":"15 1","pages":""},"PeriodicalIF":12.4,"publicationDate":"2026-11-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149359539","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Chen Tu, Meng-Xuan Dai, Zhi-Wei Huang, Yi Tang, Si-Qi Lai, Jie Zhang, Shi-Yong Le, Min-Ye He, Wen-Sheng Zhang, Jia-Wen Gao, Liang Wang
{"title":"SLC25A1/CIC supports osteoclastogenesis by coordinating mitochondrial bioenergetics and redox homeostasis.","authors":"Chen Tu, Meng-Xuan Dai, Zhi-Wei Huang, Yi Tang, Si-Qi Lai, Jie Zhang, Shi-Yong Le, Min-Ye He, Wen-Sheng Zhang, Jia-Wen Gao, Liang Wang","doi":"10.1038/s41418-026-01903-6","DOIUrl":"https://doi.org/10.1038/s41418-026-01903-6","url":null,"abstract":"<p><p>Osteoclastogenesis requires precise coordination between mitochondrial bioenergetics and anabolic programs, yet the underlying mechanisms remain unclear. Here, we identify the mitochondrial citrate carrier (CIC, encoded by SLC25A1) as a crucial link that couples mitochondrial bioenergetics to glutathione (GSH)-dependent redox regulation during osteoclastogenesis. CIC expression was elevated in the osteoclast-lineage cells from postmenopausal osteoporosis (PMOP) patients and ovariectomized (OVX) mice, and was positively correlated with classical osteoclast markers. During osteoclastogenesis, CIC was progressively upregulated. Pharmacologic inhibition of CIC with CTPI-2 not only suppressed osteoclastogenesis but also disrupted core metabolic processes, including tricarboxylic acid cycle engagement, amino acid biosynthesis, and mitochondrial respiration. Integrative transcriptomic and metabolomic profiling further revealed a compensatory shift toward enhanced GSH synthesis. Mechanistically, CIC associated with the glutamate-cysteine ligase modifier subunit (GCLM), linking mitochondrial metabolic regulation to the GSH synthetic machinery. CIC inhibition increased GCL activity, intracellular GSH content, and the GSH/GSSG ratio, accompanied by reduced reactive oxygen species accumulation. The functional importance of the GSH axis was evident, as GCL inhibition by buthionine sulfoximine partially reversed the anti-osteoclastogenic effects of CIC inhibition. Consistently, osteoclast-targeted silencing of CIC in OVX mice mitigated bone loss. Collectively, these findings support a role for CIC as a metabolic integrator of energy and redox metabolism in osteoclasts, and highlight its potential as a candidate target for limiting excessive bone resorption in PMOP.</p>","PeriodicalId":9731,"journal":{"name":"Cell Death and Differentiation","volume":" ","pages":""},"PeriodicalIF":13.6,"publicationDate":"2026-11-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149341028","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Fuwen Zuo, Mingwei Wang, Junyao Du, Xiaofeng Wang, Pengzhong Ding, Qingsheng Han, Xiaorui Liu, Wei Tang, Yu Sun, Yan Zhang, Xiaojie Wang, Min Liu, Jichao Wu, Xiaoshi Zhang, Jinlong Yu, Ziying Wang, Fan Yi
{"title":"DGKE acts as a negative regulator of podocyte migration and injury in glomerular diseases","authors":"Fuwen Zuo, Mingwei Wang, Junyao Du, Xiaofeng Wang, Pengzhong Ding, Qingsheng Han, Xiaorui Liu, Wei Tang, Yu Sun, Yan Zhang, Xiaojie Wang, Min Liu, Jichao Wu, Xiaoshi Zhang, Jinlong Yu, Ziying Wang, Fan Yi","doi":"10.1038/s41418-026-01908-1","DOIUrl":"https://doi.org/10.1038/s41418-026-01908-1","url":null,"abstract":"Podocyte injury is a major determinant of glomerular diseases. Although considerable advances have been made in the understanding of the mechanisms that trigger podocyte injury, effective cell-specific therapies remain clinically unavailable. In particular, recent studies have revealed that podocyte adhesion dysfunction and aberrant migration are pivotal events in the pathogenesis of podocyte loss and injury. Therefore, identifying candidate pathways for therapeutic intervention in podocyte migration has significant clinical importance. Here, we found that diacylglycerol kinase epsilon (DGKE) expression level is reduced in kidney biopsies from patients with glomerular diseases, which correlates with estimated glomerular filtration rate (eGFR). Moreover, urinary migrasome levels, a marker of migration, were significantly elevated in patients and negatively correlated with DGKE levels. Podocyte-specific overexpression of DGKE attenuated podocyte injury and proteinuria in three independent mouse models, adriamycin (ADR)-, puromycin aminonucleoside (PAN)- and streptozotocin plus high-fat diet (STZ/HFD)-induced nephropathy. Mechanistically, DGKE regulates podocyte migration through the urokinase plasminogen activator receptor (uPAR)/β3 integrin axis and its downstream Rac1/Cdc42 signaling cascades. Collectively, our findings provide new insights into the pivotal role of DGKE in maintaining podocyte function and suggest that DGKE may represent a potential therapeutic target for treating patients with glomerular diseases.","PeriodicalId":9731,"journal":{"name":"Cell Death and Differentiation","volume":"10 1","pages":""},"PeriodicalIF":12.4,"publicationDate":"2026-11-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149359540","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Ana C F Bolhaqueiro, Cyrille Alexandre, David Willnow, Ines Alvarez-Rodrigo, Juan Manuel Garcia-Arias, Nalle Pentinmikko, Carlos Estella, Jean-Paul Vincent
{"title":"JNK signalling balances apoptosis and cell survival during tissue stress.","authors":"Ana C F Bolhaqueiro, Cyrille Alexandre, David Willnow, Ines Alvarez-Rodrigo, Juan Manuel Garcia-Arias, Nalle Pentinmikko, Carlos Estella, Jean-Paul Vincent","doi":"10.1038/s41418-026-01894-4","DOIUrl":"https://doi.org/10.1038/s41418-026-01894-4","url":null,"abstract":"<p><p>Recovery from tissue stress requires the elimination of damaged cells and the commensurate production of healthy cells. How these two processes are coordinated to ensure tissue recovery remains poorly understood. Here we show that the c-Jun N-terminal kinase (JNK) pathway orchestrates apoptosis and proliferation, two seemingly opposite cellular behaviours, in response to epithelial stress. We took advantage of new optogenetic tools to trigger a pulse of JNK signalling activity in a defined domain of Drosophila wing primordia and mapped the response in time and space. Within 3 h after induction, the cells within the activation domain arrest proliferation, while a subset undergo apoptosis. As JNK signalling returns to background level, apoptosis subsides and proliferation resumes to allow completion of development with high fidelity. Using a sensitive reporter, we find that while JNK triggers apoptosis, the level of JNK activity does not correlate with apoptosis on a cell-by-cell basis. We show that the cell cycle phase modulates the pro-apoptotic activity of JNK signalling: G2 arrest is protective, while, in G1, mild JNK signalling activity suffices to trigger apoptosis. Transcriptomic analysis identified the genes encoding Dally and Dally-like protein (Dlp) among the most upregulated by excess JNK signalling. We show that these glypicans contribute to tissue repair by enhancing surface retention of the ligands Wingless (a Wnt) and Dpp (a BMP). We suggest that the resulting local increase in morphogen signalling provides subsequent protection from the pro-apoptotic effect of JNK signalling, allowing surviving cells to re-enter the cell cycle and resume development. Accordingly, recovery from ribosomal protein deficiency or irradiation-induced stress is impaired upon reduction of Dlp activity. Our work shows how a single stress pathway can selectively trigger apoptosis while protecting cells that can contribute to tissue recovery during resumption of normal development.</p>","PeriodicalId":9731,"journal":{"name":"Cell Death and Differentiation","volume":" ","pages":""},"PeriodicalIF":13.6,"publicationDate":"2026-11-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149341027","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Chao Zhou, Yuqing Liu, Hongyu Liu, Shuyuan Wang, Huimin Lei, Yabin Tang, Yuqing Lou, Jun Lu, Liang Zhu, Baohui Han
{"title":"ENPP1 inhibits the cGAS-STING pathway to mediate immune evasion in EGFR-TKI-resistant non-small cell lung cancer.","authors":"Chao Zhou, Yuqing Liu, Hongyu Liu, Shuyuan Wang, Huimin Lei, Yabin Tang, Yuqing Lou, Jun Lu, Liang Zhu, Baohui Han","doi":"10.1038/s41418-026-01876-6","DOIUrl":"https://doi.org/10.1038/s41418-026-01876-6","url":null,"abstract":"<p><p>Third-generation EGFR tyrosine kinase inhibitors (TKIs), such as osimertinib, have demonstrated promising clinical efficacy in the treatment of EGFR-mutant non-small cell lung cancer (NSCLC). Despite substantial progress with EGFR-TKIs, the development of acquired resistance remains a major clinical challenge. Notably, the addition of immune checkpoint blockade after TKI resistance has not resulted in significant survival benefits compared to chemotherapy. In this study, we performed a comprehensive transcriptomic analysis of established osimertinib-resistant tumor models and found that the expression of the ectonucleotide phosphodiesterase ENPP1, a key regulator of extracellular cGAMP signaling, was significantly upregulated in resistant tumors compared to the parental TKI-sensitive NSCLC tumors. Mechanistically, upregulated ENPP1 in resistant cells promoted the hydrolysis of extracellular cGAMP, suppressing the cGAS-STING pathway in immune cells and subsequently impairing immune cell activation and function, thereby promoting immune suppression and tumor progression. Genetic depletion or pharmacological inhibition of ENPP1 enhanced immune cell-mediated cytotoxicity against TKI-resistant tumor cells. Furthermore, the use of ENPP1 inhibitors both in vitro and in vivo enhanced immune cell activity and antitumor efficacy in TKI-resistant lung cancers with high ENPP1 expression. Importantly, these observations were further validated by paired clinical tumor samples, which demonstrated increased ENPP1 expression following the development of acquired EGFR-TKI resistance. Collectively, our study highlights a critical role for ENPP1 in mediating immune evasion through suppression of the cGAMP-STING pathway in the tumor immune microenvironment, supporting ENPP1 as a promising therapeutic target to enhance immunotherapy efficacy in EGFR-TKI-resistant NSCLC.</p>","PeriodicalId":9731,"journal":{"name":"Cell Death and Differentiation","volume":" ","pages":""},"PeriodicalIF":13.6,"publicationDate":"2026-11-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149341026","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Mengwen Zhang, Shumin Yan, Benzheng Zhao, Ning Ma, Keke Wang, Lin Hou, Si Chen, Mingyue Zhao, Jie Huang, Tong Ren, Xinxin Ci, Songling Zhang
{"title":"NFE2L1 promotes cisplatin resistance by attenuating ferroptosis through SLC27A2-mediated fatty acid metabolism in ovarian cancer.","authors":"Mengwen Zhang, Shumin Yan, Benzheng Zhao, Ning Ma, Keke Wang, Lin Hou, Si Chen, Mingyue Zhao, Jie Huang, Tong Ren, Xinxin Ci, Songling Zhang","doi":"10.1038/s41418-026-01897-1","DOIUrl":"https://doi.org/10.1038/s41418-026-01897-1","url":null,"abstract":"<p><p>Approaches that promote ferroptosis have emerged as promising therapeutic strategies for chemotherapy-resistant cancers; however, the mechanisms regulating ferroptosis during acquired therapeutic resistance remain incompletely understood. Using RNA sequencing, we identified that Nuclear Factor Erythroid-2 Related Factor 1 (NFE2L1) is upregulated in cisplatin-resistant ovarian cancer (OC) cells and patient tissues, as well as in ferroptosis-resistant models. Genetic knockdown of NFE2L1 resensitized cells to cisplatin both in vitro and in vivo. Notably, this effect was largely reversed by ferroptosis inhibitors, which significantly rescued cell survival following NFE2L1 depletion under cisplatin treatment. Further experiments demonstrated that modulating NFE2L1 expression affects the response to ferroptosis inducers by regulating iron accumulation and lipid peroxidation. Mechanistically, NFE2L1 silencing increased the transcription of long-chain fatty acid transport protein 2 (SLC27A2/FATP2). Chromatin immunoprecipitation and dual-luciferase reporter assays showed that NFE2L1 bound directly to the SLC27A2 promoter, where it competitively inhibited the recruitment of the transcription factor SP1. As a key member of the long-chain acyl-CoA synthetase family, FATP2 promotes the uptake and activation of long-chain fatty acids, processes that have been implicated in the regulation of ferroptosis. Subsequent LC-MS-based lipidomic analysis revealed that NFE2L1 reprogrammed intracellular fatty acid metabolism, characterized by increased polyunsaturated fatty acid (PUFA) levels and decreased monounsaturated fatty acid (MUFA) levels within phosphatidylethanolamines (PEs), thereby increasing cellular susceptibility to ferroptosis. Consistent with these findings, supplementation with exogenous unsaturated fatty acids modulated NFE2L1-mediated ferroptosis sensitivity. Collectively, our findings reveal a novel NFE2L1/SLC27A2 axis that drives cisplatin resistance in OC by suppressing ferroptosis, and suggest a potential therapeutic strategy for treating cisplatin-resistant ovarian cancer.</p>","PeriodicalId":9731,"journal":{"name":"Cell Death and Differentiation","volume":" ","pages":""},"PeriodicalIF":13.6,"publicationDate":"2026-11-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149332678","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Targeting the circ_0042819-PLA2G6 axis sensitizes multiple myeloma to proteasome inhibitors through ferroptosis induction.","authors":"Hefei Ren, Chang Liu, Zhenhua Wang, Jiafeng Zhang, Hongkun Wu, Liansheng Jiang, Tingyu Liu, Haiyan He, Qiuhui Pan, Jianxiu Yu, Lin Zhou","doi":"10.1038/s41418-026-01847-x","DOIUrl":"https://doi.org/10.1038/s41418-026-01847-x","url":null,"abstract":"<p><p>Multiple myeloma (MM) is a refractory plasma cell neoplasm characterized by frequent development of drug resistance, leading to poor clinical outcomes. Activation of ferroptosis, an iron-dependent form of cell death driven by lipid peroxidation, has emerged as a promising cancer therapeutic strategy. In this study, we show that the circular RNA circ_0042819 exhibits high expression in both bone marrow and plasma samples from MM patients, with its overexpression strongly associated with disease progression and unfavorable prognosis. Mechanistically, circ_0042819 directly interacts with Up-frameshift protein 1 (UPF1) in MM cells, and the circ_0042819-UPF1 complex upregulates the expression of phospholipase A2 group VI (PLA2G6) via interacting with, and thus stabilizing, its mRNA. Furthermore, the circ_0042819-PLA2G6 axis suppresses ferroptosis through phospholipid remodeling in MM cells. Importantly, depletion of circ_0042819 or PLA2G6 enhances MM sensitivity to proteasome inhibitors (bortezomib and carfilzomib) by promoting ferroptosis both in vitro and in vivo. Collectively, our findings demonstrate that circ_0042819 is a potential non-invasive biomarker for the diagnosis and prognosis of MM, and that inhibition of the circ_0042819-PLA2G6 axis can mitigate the resistance of MM to proteasome inhibitors through ferroptosis sensitization, thus suggesting a novel therapeutic approach.</p>","PeriodicalId":9731,"journal":{"name":"Cell Death and Differentiation","volume":" ","pages":""},"PeriodicalIF":13.6,"publicationDate":"2026-11-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149318418","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Dimitri Bulté, Alessandro Romano, Andrea Ottorini, Chiara Rigamonti, Guido Pacini, Alessia Brix, Alessandra Rocco, Federica Barzaghi, Emanuela Pettinato, Sabrina Carbone, Laura Rudilosso, Camilla Visconti, Serena Scala, Antonella Insalaco, Fabrizio de Benedetti, Roberta Caorsi, Marco Gattorno, Daniela Cesana, Anna Pistocchi, Francesca Maltecca, Alessandro Aiuti, Alessandra Mortellaro
{"title":"ADA2 controls autophagy-dependent mitochondrial fitness to restrain type I interferon activation","authors":"Dimitri Bulté, Alessandro Romano, Andrea Ottorini, Chiara Rigamonti, Guido Pacini, Alessia Brix, Alessandra Rocco, Federica Barzaghi, Emanuela Pettinato, Sabrina Carbone, Laura Rudilosso, Camilla Visconti, Serena Scala, Antonella Insalaco, Fabrizio de Benedetti, Roberta Caorsi, Marco Gattorno, Daniela Cesana, Anna Pistocchi, Francesca Maltecca, Alessandro Aiuti, Alessandra Mortellaro","doi":"10.1038/s41418-026-01893-5","DOIUrl":"https://doi.org/10.1038/s41418-026-01893-5","url":null,"abstract":"Adenosine deaminase 2 (ADA2) is a secreted enzyme recently shown to localize to lysosomes and bind DNA, yet its cellular function remains elusive. ADA2 is highly expressed by innate immune cells, particularly macrophages, which are implicated in the inflammatory pathogenesis of ADA2 deficiency (DADA2). Accordingly, we investigated its function in macrophages and identified ADA2 as a key regulator of mitochondrial quality control. Transcriptomic profiling of patient monocytes revealed upregulation of nuclear-encoded mitochondrial genes, alongside stress-response and apoptotic programs. Consistently, ADA2-deficient macrophages exhibited increased mitochondrial mass, hyperpolarization, elevated mitochondrial ROS and ATP production, structural abnormalities in cristae, and defective mitophagy. These defects promoted mitochondrial DNA leakage via VDAC, triggering cytosolic DNA sensing, cGAS–STING activation, and hyperactive JAK–STAT–mediated IFN-I responses. Restoration of ADA2 partially rescued mitochondrial integrity and dampened IFN hyperactivation in macrophages and zebrafish. Together, our findings identify ADA2 as a key regulator of mitochondrial quality control that prevents organelle dysfunction and limits inflammation driven by aberrant IFN signaling.","PeriodicalId":9731,"journal":{"name":"Cell Death and Differentiation","volume":"12 1","pages":""},"PeriodicalIF":12.4,"publicationDate":"2026-10-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149305426","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}